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The skin epidermis is a multipurpose barrier (i.e., against epidermal permeability disruption and
oxidative/UV irradiation) as well as a mechanical barrier and antimicrobial barrier, to protect cells/tissues
from external perturbants. When there is a normal barrier, function is restored and/or enhanced in the
epidermis in response to external perturbations. Ceramide (Cer) is a well-known, key lipid constituent of
the epidermal permeability barrier in the extracellular domain of the stratum corneum. Cer and its
metabolites also serve as signaling lipids to regulate cellular function (e.g., proliferation, differentiation,
and apoptosis). Recent studies from our laboratory demonstrate that the Cer metabolites, sphingosine-1-
phosphate (S1P) and ceramide-1-phosphate (C1P), generate signaling transcriptionally to stimulate
cathelicidin antimicrobial peptide (CAMP), and human beta-defensin (hBD) 2 and hBD3 production,
respectively, in cells, including in epidermal keratinocytes. S1P and C1P production are increased by
external perturbation-induced endoplasmic reticulum stress. These studies illuminate a mechanism
through which external perturbations signal to stimulate antimicrobial peptides without evidence of
microbial infections. In this work, we describe the signaling roles of Cer, S1P, and C1P in cells.
Copyright © 2015, Taiwanese Dermatological Association.
Published by Elsevier Taiwan LLC. All rights reserved.Introduction
Ceramide (Cer) is composed of long-chain aminoalcohol and
amide-linked fatty acids, whose chain lengths are 18e20 and
16e24, respectively (Figure 1). Cer serves as a membrane con-
stituent and also as the backbone of all complex sphingolipids. It is
converted to metabolites, and Cer and its metabolites regulate
cellular functions (Figure 2). In skin, Cer serves as a key compo-
nent in the epidermal permeability barrier in the stratum cor-
neum. We review the signaling roles of Cer and its metabolites in
skin. To distinguish between Cer forming epidermal permeability
barrier structures and Cer regulating cellular function, the formery have no ﬁnancial or non-
atter or materials discussed
0) Veterans Affairs Medical
CA 94158, USA.
).
cal Association. Published by Elsevand the latter are referred to as “barrier Cer” and “signaling Cer,”
respectively.
Ceramide for epidermal permeability barrier
An epidermal permeability barrier is required for survival of
mammals living in dry terrestrial environments. Major barrier
lipids consist of cholesterol, free fatty acid, and Cer, which lo-
calizes in the extracellular lipids in the stratum corneum and is a
key permeability barrier constituent. At least nine molecular
classes of Cer, in both bulk amounts and molecular heterogeneity,
located in the stratum corneum are unique to skin.1,2 Prior
studies show that decreased contents of Cer and/or alteration of
molecular species occur in some cutaneous diseases associated
with permeability barrier abnormality, i.e., atopic dermatitis (AD),
psoriasis, and certain ichthyoses.3e5 Furthermore, it has been
recently demonstrated that a minor Cer metabolite species,
sphingosine, also contributes to form a competent permeability
barrier structure.6,7ier Taiwan LLC. All rights reserved.
Figure 1 Ceramide structure.
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Figure 3 Ceramide (Cer) metabolic pathway. Cer is synthesized de novo pathway
catalyzed by (A) serine palimoyltransferase, ceramide synthase, and desaturase, hy-
drolysis of sphingomyelin or glucosylceramide by (B) sphingomyelinase or (C) b-glu-
cocerebrosidase, respectively. Conversely, sphingomyelin and glucosylceramide are
synthesized from Cer by (D) sphingomyelin synthase and (E) UDP-glucosylceramide
transferase, respectively. (F) Cer is hydrolyzed to sphingosine by ceramidase. (G)
Sphingosine is phosphorylated to sphingosine-1-phosphate (S1P) by sphingosine ki-
nase, and conversely, (H) S1Pis hydrolyzed to sphingosine by sphingosine-1-phosphate
phosphatase. (I) S1P is dephosphorylated to phosphoethanolamine and hexadecanal
by sphinosine-1-phosphate lyase. (J) Cer is phosphorylated to ceramide-1-
phophosphate by ceramide kinase and conversely, (K) ceramide-1-phophosphate is
dephosphorylated to Cer by ceramide-1-phosphate phosphatase.
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and Cer for signaling
The differences between Cer responsible for permeability barrier
formation in the stratum corneum and signaling Cer are summa-
rized below.
(1) Localization. As stated above, barrier Cer is localized in the
extracellular spaces in the stratum corneum. In contrast,
signaling Cer regulates cellular function on the plasma
membrane or intracellular compartment in cells, including
nuclear layers of epidermal keratinocytes.
(2) Content. Cer in the stratum corneum is present in millimolar
quantities, which contribute to form the epidermal perme-
ability barrier,8 whereas plasma membrane or intracellular
Cer has micromolar levels.
(3) Molecular species. Heterogeneous molecules of Cer are pre-
sent in the stratum corneum, and such heterogeneity is
required for formation of uniform lamellar membrane
structures. It has been shown that Cer species that consist of
N-nonhydroxyl fatty acid and sphingosine can regulate bio-
logical processes. Certain Cer species (chain lengths of
amide-linked fatty acid 16) lack antimitogenic or proapo-
ptotic features, which leads to increased apoptosis in squa-
mous cell carcinoma cells in response to endoplasmic
reticulum (ER) stress. However, the structure requirements
of signaling Cer are largely unknown.Ceramide metabolites
Cer is converted into four metabolic pathways (Figure 3).
(1) Choline phosphorylated to sphingomyelin by sphingomyelin
synthase 1 or sphingomyelin synthase 2. The former isCeramide
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Figure 2 Roles of ceramide and its metabolites in epidermis.localized in the trans Golgi apparatus and latter is in the
plasma membrane.
(2) Glycosylated toglucosylceramidebyUDP-glucosyltransferase
or galactosylceramide by UDP-galactosyltransferase to syn-
thesize glucosylceramide and galactosyloceramide, respec-
tively. Glucosylceramide, but not galactosylceramide, is
synthesized in epidermal keratinocyte.
(3) 1-0-phosphorylated to ceramide-1-phosphate (C1P) by cer-
amide kinase.
(4) Hydrolyzed to aminoalcohol and fatty acid by ceramidase.
Four isoforms of ceramidased(1) acidic ceramidase distributed
in lysosome; (2) neutral ceramidase in plasma membrane and ER;
(3) alkaline ceramidase 2 (so-called skin ceramidase) in ER and
alkaline ceramidase 3 in Golgi apparatus; (4) phytoalkaline
ceramidase (alkaline ceramidase 1) in ERdhave been identiﬁed in
mammals. Alkaline ceramidase 2 has been shown only in differ-
entiated layers in the epidermis. Four ceramidase isoforms are
present in keratinocytes, whereas both acidic and alkaline ceram-
idase 2 levels are increased and alkaline ceramidase 1 levels are
decreased during keratinocyte differentiation.1 The other three
ceramidase levels are not changed in a differentiation-dependent
manner. Moreover, glycosylceramides are further glycosylated to
di- or polyglycosylceramide. In the epidermis, glucosylceramides
are a major species. Sphingosine is phospholyated to sphingosine-
1-phosphate (S1P) by sphingosine kinase 1 or 2.
Glucosylceramide is hydrolyzed to glucose and ceramide by b-
glucocerebrosidase, whereas sphingomyelin is hydrolyzed to
sphingosine and phosphorylcholine by sphingomyelinase.
Signaling Cer can be produced from hydrolyses of sphingo-
myelin or glucosylceramide, by sphingomyelinase or b-glucocere-
brosidase, respectively, as well as de novo synthesis by activation of
either serine-palimitoyltransferase or ceramide synthase.1,9 In
contrast to the sphingomyelin pathway that generates signaling
Cer, the glucosylceramide pathway has not been elucidated. Our
prior studies demonstrated that Cer production is increased
following ultraviolet (UV) B irradiation or other oxidative stressors
and results in increasing Cer-induced apoptosis in keratinocytes.10
Both toxic (high doses) and subtoxic (low doses) increased cer-
amide, whereas toxic levels of irradiation sustained elevated Cer;
however, Cer was restored toward normal levels in cells treated
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nonapoptotic Cer metabolites,10 suggesting that metabolic con-
version contributes to protecting cells against Cer-induced
apoptosis. Cer-induced apoptosis is in part a mechanism of
chemotherapy, whereas acceleratingmetabolic conversion of Cer to
glucosylceramide and S1P-attenuating chemotherapy has been
shown in several types of tumor cells, including melanoma. In
particular, the chemotherapy-resistant tumor cells often show
increased enzyme production, which is responsible for the meta-
bolic protective mechanism against Cer-induced apoptosis.11,12
Cer signaling roles that regulate cellular functions
The ﬁrst demonstration of a Cer signaling role (to induce erythro-
blast maturation) was in 1974. The ﬁrst barrier Cer studies, reported
in 1975 by Gray and Yardley,13 initiated the ﬁeld of skin Cer
research. In contrast, Cer signaling studies were not further
developed for some time. In early 1990, it was shown that
increasing cellular Cer levels by sphinomyelinase activation
induced cell cycle arrest and differentiation in leukemia cells in
response to vitamin D or phorbol ester.14,15 A technical difﬁculty of
Cer biological studies is the poor solubility of Cer in aqueous so-
lution. The application of cell-permeable short-chain amide-linked
fatty acid (C2eC8) containing Cer, which substantially increased
hydrophilicity, has led to more signaling Cer studies. Although such
short-chain Cer is not synthesized in mammalian cells, it can be
used as a precursor to synthesize natural, long-chain Cer in cells.16
Previous studies demonstrated that, in response to various stimuli,
including ER stress, sphingomyelin hydrolysis by sphingomyelinase
activation and/or de novo synthesis of Cer by ceramide synthase
activation generate signaling Cer.17e19
Cer mechanisms that regulate cellular functions depend on cell
types and/or stimuli.12,20
The following downstream mechanisms have been demon-
strated in mammalian cells:
(1) Increased cellular Cer activates ceramide-activating serine/
threonine phosphatases (CAPS)di.e., protein phosphatase
1A (PP1A) and protein phosphatase 2A (PP2A),21 protein ki-
nase C (PKC) z,22 cathepsin D,23 and kinase suppressor RAS.24
(2) CAPS, PP1A, and PP2A inactivate PKCa,25 and AKT [or protein
kinase B (PFB)],26 depending on cell and tissue types as well
as stimuli.
In addition to these mechanisms, Cer physically affect cellular
functions. Cer permeabilizes mitochondrial outer membranes,
leading to mitochondrial-mediated apoptosis.27
Signaling roles of Cer metabolites in regulation of
antimicrobial peptide production
Skin deploys multiple barriers to protect cells and tissues from
external perturbationsdi.e., UV/oxidative stress, mechanical stress,
andmicrobial infection. The antimicrobial peptide (AMP), an innate
immune component, is a key constituent of the antimicrobial bar-
rier. Microbial infection increases AMP production, whereas diverse
types of external perturbationsdsuch as epidermal permeability
disruption, UV irradiation, and other types of oxidative stressd
stimulate key epidermal AMP [cathelicidin antimicrobial peptide
(CAMP), human beta-defensin (hBD) 1, hBD2 and hBD3 produc-
tion]. Although all perturbations increase the risk of microbial in-
fections, AMP production is increased in skin without infections
following perturbations. Our recent studies demonstrate that acute
epidermal permeability defects, as well as UVB/oxidative stress
induce ER stress in keratinocytes.28,29 The ER is an intracellularorganelle that synthesizes protein and lipid, and is a major storage
place for Ca2þ. ER stress occurs in cells when proteins are accu-
mulated and Ca2þ is released from the ER. Three major trans-
membrane proteinsdinositol-requiring enzyme 1 (IRE1 or ERN1, a
kinase with ribonuclease activity), protein kinase RNA-like endo-
plasmic reticulum kinase (PERK; also known as PEK or EIF2AK3),
and activating transcription factor 6dserve as sensors of ER stress
and also induce rescue signals to restore cellular function, because
ER stress causes deleterious cell effects, including apoptosis.30
However, high levels of ER stress levels cause apoptosis. We
found that ER stress stimulates both CAMP and hBD2 and hBD3, but
not hBD1, production.31,32 These studies demonstrate how different
external perturbations can increase speciﬁc AMP production
through one mechanism.
CAMP production
CAMP is a multifunctional AMP that is not only antimicrobial, but
also accelerates cell growth, cell motility, angiogenesis, and certain
cytokine production.33,34 As discussed above, CAMP production is
stimulated following external perturbation that can induce ER
stress in parallel with increasing cellular Cer production. Prior
studies characterized that a nuclear hormone receptor, vitamin D
receptor (VDR), is dependent on the stimulation of CAMP produc-
tion.35 Microbial infection activates Toll-like receptor 2. Toll-like
receptor 2 does not activate VDR, but does activate 25-hydroxy
vitamin D3 1-alpha-hydroxylase (CYP27B1), which synthesizes a
VDR ligand 1a, 25-dihydroxy vitamin D3, leading to stimulation of
CAMP production. VDR binding sequence has not been identiﬁed
on the promoter region of binding sequence on a murine CAMP
(CRAMP) gene,35 as opposed to the human CAMP gene. Impor-
tantly, we found that VDR transcription activity is suppressed in
cells under ER stress, and VDR gene silencing does not alter
increased CAMP production.28 Recent studies further identiﬁed
that a Cer metabolite, S1P, activates transcription factor nuclear
factor-kappa B (NF-kB).31 The NF-kB binding sequence is not
identiﬁed on a CAMP promoter.28,35 NF-kB then activates another
transcription factor C/EBPa (by MAP kinase activation) that stim-
ulates CAMP transcription28 (Figure 4). S1P-mediated signaling of
cellular functions is often dependent on prior binding to one or
more of ﬁve known G-protein-coupled S1P receptors (S1P1eS1P5),
located on the outer surface of the plasma membrane.36 KC express
all ﬁve receptors.37 However, S1P activates NF-kB via the S1P
receptor-independent pathway intracellular region.31
hBD2 and hBD3 production
Both hBD2 and hBD3 are stimulated by microbial infections,
whereas upstream mechanisms to regulate these hBDs are
different. Proinﬂammatory cytokines (interleukin-1b, tumor ne-
crosis factor-a, interferon-g) induce hBD-2 mRNA transcription by
activation.38 hBD3 production is induced by epidermal growth
factor receptor activation.39 Other transcriptional factors, signal
transducer and activator of transcription (STAT) 1 and STAT 3, also
serve as downstream signals to regulate hBD2 and hBD 3 tran-
scription.40,41 Recent studies have shown that C1P is increased
following increased Cer production, in response to external
perturbation and ER stress.32
C1P directly activates cytosolic phospholipase A2 to rerelease
arachinonate from glycerophospholipids, leading to increased
eicosanoid production, including PGE2 and PGJ2. Prior study
showed that C1P-mediated, elevated PGE2 levels increase inﬂam-
matory responses in cells.42 C1P also increased PGJ2 production
followed by stimulation of hBD2 and hBD3 production.32 PGJ2 is an
activator of nuclear hormone receptors, peroxisome proliferator-
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Figure 4 Ceramide metabolite, sphingosine-1-phosphate signals to stimulate cathelicidin antimicrobial peptide (CAMP) production.
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hBD2 and hBD3 production through PPARa and PPARb/ddbut not
PPARgdactivation.32 Then, PPARa and PPARb/d activate STAT1 and
STAT 3 via the activation of tyrosine Src kinase. STAT 1 and STAT 3
are activated by phosphorylation that binds to promoter sequences
of hBD2 or hBD3, leading to hBD2 and hBD3 production32
(Figure 5).
Pharmacological modulation and clinical implication of CAMP
production
Recent studies have demonstrated that certain naturally occurring
polyphenolic compounds, such as stilbenoid, resveratrol, and the
soy-derived isoﬂavone, genistein, increase cellular levels of S1P thatFigure 5 Ceramide metabolite, ceramide-1-phosphate signals to ssignal to stimulate production of the key epidermal AMP,
CAMP.44,45 Resveratrol and genistein increased S1P production via
different signalingmechanisms (Figure 6): (1) resveratrol increased
not only ceramide, but also its key metabolites, sphingosine and
S1P; (2) genistein increased production of S1P (without changes in
ceramide levels) by inhibiting the activity of S1P lyase, an enzyme
catalyzing S1P breakdown to phosphoethanolamine and hex-
adecenal, as well as increasing expression of key enzymesde.g.,
acidic/alkaline ceramidases and sphingosine kinase 1 (SPHK1),
which convert ceramide to S1P. In addition to both naturally
occurring compounds, our more recent studies suggested that
direct activation of SPHK1 with a chemically synthesized com-
pound, (S)-methyl 2-(hexanamide)-3-(4-hydroxyphenyl) prop-
anoate (defensamide), can also stimulate CAMP production via ourtimulate human beta-defensin (hBD) 2 and hBD3 production.
Figure 6 Pharmacological enhancement of cathelicidin antimicrobial peptide (CAMP) production.
Y. Uchida et al. / Dermatologica Sinica 33 (2015) 78e8382identiﬁed S1P-dependent mechanism (unpublished data)
(Figure 6). These studies indicate multiple target points whereby
naturally occurring or chemically synthesized compounds increase
production of S1P that could enhance antimicrobial defense
through the stimulation of CAMP production.44,45
In addition, curcumin stimulates CAMP production via the VDR-
independent pathway.46 Because patients with AD do not produce
enough CAMP in response to microbial pathogens, bacterial in-
fections are a serious and frequent complication of AD patients.
Therefore, these individual compounds, which can stimulate CAMP
production, are potentially useful for the development of novel
potential therapeutic agents and/or cosmetic products to enhance
antimicrobial defense in AD.Conclusion
Cer and its metabolites exhibit multifunctions in mammalian cells,
including keratinocytes. In contrast to barrier Cer, even a 1/1000
part of Cer concentration will sufﬁce to generate signals to alter
cellular function. Because such a small change occurs in certain
cellular compartment(s) and/or basal Cer, S1P, and C1P levels are
low, increased levels of Cer or its metabolites could have a great
impact on cells. A rescuemechanism, metabolic conversion, against
Cer-induced apoptosis enhances innate immunity through AMP
production. Hormesis shows that low levels of external perturba-
tions, including radiation, and oxidative stress, enhance the cellular
antioxidant system (superoxide dismutase) and thioredoxin, a tu-
mor suppressor gene p53, and heat shock proteins.47 Similarly, low
levels of Cer and its metabolites could enhance defense against
these external perturbants in cells.References
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